Norman J. Lacayo, MD
Academic Appointments
- Assistant Professor - Med Center Line, Pediatrics - Hematology & Oncology
Key Documents
Contact Information
-
Clinical Offices
Bass Cancer Center- LPCH 725 Welch Rd MC 5913 Palo Alto, CA 94304 Tel Work (650) 497-8953 Fax (650) 497-8959Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-5535Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Hematology/Oncology/Stem Cell Transplant, Pediatric
- Oncology (Cancer), Pediatric
- AML, childhood and adolescent/young adult
- ALL, childhood and adolescent/young adult
- lymphoblastic lymphoma, childhood
- Hematology/Oncology
Administrative Appointments
- Myeloid Steering Committee, Children's Oncology Group (2007 - present)
- Member, Cancer Center (2007 - present)
Honors and Awards
- Molecular and Pharmacologic Correlates of Acute Myeloid Leukemia in Down Syndrome, NIH ROI subcontract from Wayne State University (01/09-04/16)
- Banking Acute Leukemia Specimens at Lucile Packard Childrens Hospital: Hyundai Infrastructure Grant, Hyundai Foundation (10/11-09/12)
- New Approaches in Pediatric Myeloid Leukemia, V Foundation (10/09-09/12)
- Member, Alpha Omega Alpha (1990)
Professional Education
| Internship: | UCSF Medical Center, CA USA (1990) |
| Residency: | UCSF Medical Center CA (1992) |
| Board Certification: | Hematology/Oncology, American Board of Pediatrics (1996) |
| Fellowship: | Stanford University Medical Center CA (1995) |
| Medical Education: | UCSF School of Medicine CA (1989) |
| MD: | U.C., San Francisco, Medicine (1989) |
Internet Links
Scientific Focus
Current Research Interests
Pediatric Hematology/Oncology, Phase I drug studies for refractory and relapsed leukemia; genomic studies, biologic risk-stratification and treatment of acute myeloid leukemia; prediction or induction response and risk of relapse using phosphoproteomics in childhood AML; novel MRD techniques in childhood ALL.
Clinical Trials
- Not Recruiting Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
- Recruiting Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
- Recruiting A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
- Not Recruiting A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
- Not Recruiting Ixabepilone in Treating Young Patients With Refractory Solid Tumors
Publications
- Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. Leukemia. 2013; (3): 731-4
- Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML. Leuk Res. 2012; (7): 900-4
- Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012; (2): e30733
- Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood. 2012; (22): 4407-17
- A pilot study of an online cognitive rehabilitation program for executive function skills in children with cancer-related brain injury. Brain Inj. 2011; (1): 101-12
- Dorsolateral midbrain MRI abnormalities and ocular motor deficits following cytarabine-based chemotherapy for acute myelogenous leukemia. J Neuroophthalmol. 2011; (1): 52-3
Help